TickerFacts.

AIM ImmunoTech Inc. (AIM): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$14.91M
Year ended 2024-12-31
2009-12-31: -$9.63M2010-12-31: -$12.62M2011-12-31: -$11.90M2012-12-31: -$18.89M2013-12-31: -$17.73M2014-12-31: -$14.47M2015-12-31: -$16.29M2016-12-31: -$7.54M2017-12-31: -$7.96M2018-12-31: -$10.69M2019-12-31: -$9.13M2020-12-31: -$10.39M2021-12-31: -$14.01M2022-12-31: -$16.19M2024-12-31: -$14.91M-$14.91M
2009-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$14.91Mn/a2026-03-27, From 2024-01-01
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31-$16.19Mn/m2024-04-01, From 2022-01-01
2021-12-31-$14.01Mn/m2023-03-31, From 2021-01-01
2020-12-31-$10.39Mn/m2022-03-31, From 2020-01-01
2019-12-31-$9.13Mn/m2021-03-31, From 2019-01-01
2018-12-31-$10.69Mn/m2020-03-30, From 2018-01-01
2017-12-31-$7.96Mn/m2019-04-01, From 2017-01-01
2016-12-31-$7.54Mn/m2018-03-30, From 2016-01-01
2015-12-31-$16.29Mn/m2018-03-30, From 2015-01-01
2014-12-31-$14.47Mn/m2017-03-31, From 2014-01-01
2013-12-31-$17.73Mn/m2016-03-29, From 2013-01-01
2012-12-31-$18.89Mn/m2015-03-19, From 2012-01-01
2011-12-31-$11.90Mn/m2014-03-14, From 2011-01-01
2010-12-31-$12.62Mn/m2013-03-18, From 2010-01-01
2009-12-31-$9.63Mn/a2012-03-14, From 2009-01-01